Adult Acute Lymphoblastic Leukemia — Trials

Adult Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

249 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 44
Recruiting: 21
Ph III recruiting: 1
Growth YoY: —
Industry share: 7%
Top sponsor: Institute of Hematology & Blood Diseases Hospital, China
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (37)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05895201	High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Sitagliptin for the Prevention of GVHD	withdrawn	Phase 1 / Phase 2	0	Indiana UniversityOTHER	1	Apr 29, 2024	clinicaltrials
NCT02861040	Volasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia	withdrawn	Phase 1	0	Northwestern UniversityOTHER	1	Dec 15, 2016	clinicaltrials